Ascentage Pharma Group International - ADR (36X0)
Market Closed
14 Aug, 20:00
XDUS XDUS Primary €
15. 40
-0.2
-1.2821%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 15.6
Previous Close Want to track 36X0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ascentage Pharma Group International - ADR (36X0) Statistics
Valuation metrics
Market Cap -
Enterprise value -484.68M
Trailing P/E (ttm) -1.11
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -0.84
Enterprise Value/EBITDA 0.45
Overview
Shares outstanding 373.32M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3
Average volume (90 days) 1
Price summary
52-Week low 13
52-Week high 40
Beta -
50-Day moving average 19.51
200-Day moving average 25.05
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.91%
Operating margin -2.06%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.93%
Income Statement
Revenue (ttm) 574.12M
Revenue per share (ttm) 6.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) 525.18M
EBITDA -
Net income to common (ttm) -1.24B
Diluted EPS (ttm) -13.96
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.2B
Total cash per share (mrq) -
Total debt (mrq) 1.98B
Total Debt/Equity (mrq) 1.48
Current ratio (mrq) 1.79%
Book value per share (mrq) -
Cash Flow
Cash flow statement -1.22B
Levered free cash flow (LFCF) -1.24B
